Strengthen the construction of tertiary prevention and treatment network of retinopathy of prematurity in China_Chinese Journal of Ocular Fundus Diseases

Authors：

 Chen Changzheng , Wang Xiaoling

Eye Center of the Renmin Hospital of Wuhan University, Wuhan 430000, China;

Corresponding author：

Chen Changzheng, Email: whuchenchzh@163.com

Keywords：

Retinopathy of prematurity; Preventive medicine; Editorial

DOI：

10.3760/cma.j.cn511434-20220525-00322

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

The prevention and treatment of retinopathy of prematurity (ROP) is an important strategic content of blindness prevention and treatment in China. Medical institutions including remote areas have strengthened the awareness of neonatal fundus screening, however, there are problems of vague screening standards, mainly manifested in expanding the scope of screening and even universal screening of newborns. At the same time, all kinds of fundus changes found in the examination cannot be correctly interpreted and handled, which increase the economic and psychological burden of children's families. In addition, with the wide application of intravitreal injection of anti-neovascular endothelial growth factor, problems such as improper grasp of indications and improper treatment of complications have become increasingly prominent. At this stage, it is urgent to strengthen the construction of ROP prevention and control network, which is suitable for China's national conditions, led by the government and coordinated participation of health and medical institutions at all levels.

Citation： Chen Changzheng, Wang Xiaoling. Strengthen the construction of tertiary prevention and treatment network of retinopathy of prematurity in China. Chinese Journal of Ocular Fundus Diseases, 2022, 38(7): 526-530. doi: 10.3760/cma.j.cn511434-20220525-00322 Copy

1.	中华医学会眼科学分会眼底病学组. 中国早产儿视网膜病变筛查指南(2014年)[J]. 中华眼科杂志, 2014, 50(12): 933-935. DOI: 10.3760/cma.j.issn.0412-4081.2014.12.017.Fundus Disease Group of Ophthalmology Branch of Chinese Medical Association. Guidelines for Retinopathy of Prematurity Screening in China (2014)[J]. Chin J Ophthalmol, 2014, 50(12): 933-935. DOI: 10.3760/cma.j.issn.0412-4081.2014.12.017.
2.	Hellström A, Smith LE, Dammann O. Retinopathy of prematurity[J]. Lancet, 2013, 382(9902): 1445-1457. DOI: 10.1016/S0140-6736(13)60178-6.
3.	王雨生, 张自峰, 李曼红, 等. 西安地区早产儿视网膜病变筛查的初步结果[J]. 中华眼科杂志, 2010, 46(2): 119-124. DOI: 10.3760/cma.j.issn.0412-4081.2010.02.006.Wang YS, Zhang ZF, Li HM, et al. Preliminary results of screening of retinopathy of prematurity in Xi'an[J]. Chin J Ophthalmol, 2010, 46(2): 119-124. DOI: 10.3760/cma.j.issn.0412-4081.2010.02.006.
4.	张国明, 曾键, 黄丽娜, 等. 深圳早产儿视网膜病变筛查结果分析[J]. 中华眼底病杂志, 2008, 24(1): 38-40.Zhang GM, Zeng J, Huang LN, et al. Screening results of retinopathy of prematurity in preterm infants in 3 hospitals in Shenzhen[J]. Chin J Ocul Fundus Dis, 2008, 24(1): 38-40.
5.	苏钰, 陈长征, 李璐, 等. 湖北地区早产儿视网膜病变筛查结果及相关因素分析[J]. 中华眼底病杂志, 2012, 28(1): 53-56. DOI: 10.3760/cma.j.issn.1005-1015.2012.01.014.Su Y, Cheng CZ, Li L, et al. Screening and risk factors analysis of retinopathy of prematurity in Hubei[J]. Chin J Ocul Fundus Dis, 2012, 28(1): 53-56. DOI: 10.3760/cma.j.issn.1005-1015.2012.01.014.
6.	赵家良. “视觉2020”行动与我国防盲治盲工作[J]. 中华眼科杂志, 2002, 38(10): 577-579. DOI: 10.3760/j:issn:0412-4081.2002.10.001.Zhao JL. "Vision 2020" and prevention of blindness in China[J]. Chin J Ophthalmol, 2002, 38(10): 577-579. DOI: 10.3760/j:issn:0412-4081.2002.10.001.
7.	玛依努尔·于苏甫, 王宁利. “视觉2020”: 中国防盲治盲与眼健康工作进展[J]. 中华医学杂志, 2020, 100(48): 3831-3834. DOI: 10.3760/cma.j.cn112137-20200825-02468.Mayinuer YSF, Wang NL. "Vision 2020": the progress of blindness prevention and eye health in China[J]. Natl Med J China, 2020, 100(48): 3831-3834. DOI: 10.3760/cma.j.cn112137-20200825-02468.
8.	黎晓新. 重视早产儿视网膜病变的防治[J]. 中华眼科杂志, 2005, 41(4): 289-291. DOI: 10.3760/j:issn:0412-4081.2005.04.001.Li XX. Emphasizing the prevention and treatment for retinopathy of prematurity[J]. Chin J Ophthalmol, 2005, 41(4): 289-291. DOI: 10.3760/j:issn:0412-4081.2005.04.001.
9.	赵培泉, 张琦, 许宇. 提高小儿视网膜疾病的认知水平, 推动我国小儿视网膜疾病研究的深入开展[J]. 中华眼底病杂志, 2014, 30(1): 1-5. DOI: 10.3760/cma.j.issn.1005-1015.2014.01.001.Zhao PQ, Zhang Q, Xu Y. The diagnosis and treatment of pediatric retinal disease[J]. Chin J Ocul Fundus Dis, 2014, 30(1): 1-5. DOI: 10.3760/cma.j.issn.1005-1015.2014.01.001.
10.	王雨生, 李蓉. 重视我国早产儿视网膜病变的防治工作[J]. 中华眼科杂志, 2011, 47(6): 483-486. DOI: 10.3760/cma.j.issn.0412-4081.2011.06.002.Wang YS, Li R. Pay attention to the prevention and treatment of retinopathy of prematurity in China[J]. Chin J Ophthalmol, 2011, 47(6): 483-486. DOI: 10.3760/cma.j.issn.0412-4081.2011.06.002.
11.	陆方. 开展小儿视网膜疾病影像检查, 提高小儿视网膜疾病诊断治疗水平[J]. 中华眼底病杂志, 2014, 30(1): 9-11. DOI: 10.3760/cma.j.issn.1005-1015.2014.01.003.Lu F. Imaging technology and the diagnosis and treatment of pediatric retinal disease[J]. Chin J Ocul Fundus Dis, 2014, 30(1): 9-11. DOI: 10.3760/cma.j.issn.1005-1015.2014.01.003.
12.	儿童眼及视力保健技术规范[J]. 中华眼科杂志, 2013, 49(7): 651-652. DOI: 10.3760/cma.j.issn.0412-4081.2013.07.017.Technical specification for children's eye and vision care[J]. Chin J Ophthalmol, 2013, 49(7): 651-652. DOI: 10.3760/cma.j.issn.0412-4081.2013.07.017.
13.	Emerson MV, Pieramici DJ, Stoessel KM, et al. Incidence and rate of disappearance of retinal hemorrhage in newborns[J]. Ophthalmology, 2001, 108(1): 36-39. DOI: 10.1016/s0161-6420(00)00474-7.
14.	Callaway NF, Ludwig CA, Blumenkranz MS, et al. Retinal and optic nerve hemorrhages in the newborn infant: one-year results of the newborn eye screen test study[J]. Ophthalmology, 2016, 123(5): 1043-1052. DOI: 10.1016/j.ophtha.2016.01.004.
15.	李丽红, 李娜, 卢军, 等. 昆明市妇幼保健院新生儿眼病筛查4年回顾[J]. 中国妇幼保健杂志, 2015, 30(18): 2686-2690. DOI: 10.7620/zgfybj.j.issn.1001-4411.2015.18.33.Li LH, Li N, Lu J, et al. Review of neonatal eye disease screening in Kunming Maternal and Child Health Hospital in 4 years[J]. Maternal & Child Health Care of China, 2015, 30(18): 2686-2690. DOI: 10.7620/zgfybj.j.issn.1001-4411.2015.18.33.
16.	张建萍, 马金瑜, 韦丽芳, 等. 新生儿眼底出血及其相关影响因素分析[J]. 中华眼底病杂志, 2015, 31(2): 153-156. DOI: 10.3760/cma.j.issn.1005-1015.2015.02.011.Zhang JP, Ma JY, Wei LF, et al. Retinal hemorrhages in newborns and associated factors[J]. Chin J Ocul Fundus Dis, 2015, 31(2): 153-156. DOI: 10.3760/cma.j.issn.1005-1015.2015.02.011.
17.	杜婉丽, 吴彩云, 张瑜, 等. 足月新生儿眼底出血的高危因素分析[J]. 中国斜视与小儿眼科杂志, 2017, 25(2): 6-9. DOI: 10.3969/J.ISSN.1005-328X.2017.02.002.Du WL, Wu CY, Zhang Y, et al. The high-risk factors for newborn fundus hemorrhages[J]. Chinese Journal of Strabismus & Pediatric Ophthalmology, 2017, 25(2): 6-9. DOI: 10.3969/J.ISSN.1005-328X.2017.02.002.
18.	朱文珲, 骆荣江, 刘韶瑞. 高危新生儿眼底出血临床分析[J]. 中华眼底病杂志, 2012, 28(5): 482-484. DOI: 10.3760/cma.j.issn.1005-1015.2012.05.012.Zhu WH, Luo RJ, Liu SR. Clinical analysis of retinal hemorrhages in high-risk infants[J]. Chin J Ocul Fundus Dis, 2012, 28(5): 482-484. DOI: 10.3760/cma.j.issn.1005-1015.2012.05.012.
19.	Egge K, Lyng G, Maltau JM. Retinal haemorrhages in the newborn[J]. Acta Ophthalmol (Copenh), 1980, 58(2): 231-236. DOI: 10.1111/j.1755-3768.1980.tb05715.x.
20.	Egge K, Lyng G, Maltau JM. Effect of instrumental delivery on the frequency and severity of retinal hemorrhages in the newborn[J]. Acta Obstet Gynecol Scand, 1981, 60(2): 153-155.
21.	Watts P, Maguire S, Kwok T, et al. Newborn retinal hemorrhages: a systematic review[J]. J AAPOS, 2013, 17(1): 70-78. DOI: 10.1016/j.jaapos.2012.07.012.
22.	Von Barsewisch B. Perinatal retinal haemorrhages: morphology, aetiology, and significance[M]. New York: Springer-Verlag, 1979: 71-118.
23.	Berkus MD, Ramamurthy RS, O'Connor PS, et al. Cohort study of silastic obstetric vacuum cup deliveries: Ⅰ. safety of the instrument[J]. Obstet Gynecol, 1985, 66(4): 503-509.
24.	李丽红, 张国明, 李娜, 等. 新生儿视网膜出血分级标准探讨[J]. 中国妇幼保健, 2017, 32(15): 3572-3574. DOI: 10.7620/zgfybj.j.issn.1001-4411.2017.15.60.Li LH, Zhang GM, Li N, et al. Discussion on the grading standard of neonatal retinal hemorrhage[J]. Maternal & Child Health Care of China, 2017, 32(15): 3572-3574. DOI: 10.7620/zgfybj.j.issn.1001-4411.2017.15.60.
25.	Tang H, Li N, Li Z, et al. Collaborating group of neonatal ocular birth defects and genetic diseases in China. Fundus examination of 199 851 newborns by digital imaging in China: a multicentre cross-sectional study[J]. Br J Ophthalmol, 2018, 102(12): 1742-1746. DOI: 10.1136/bjophthalmol-2018-312366.
26.	马燕, 邓光达, 麻婧, 等. 婴幼儿眼病筛查中视网膜白色病灶的病因初探[J]. 眼科, 2018, 27(3): 211-214. DOI: 10.13281/j.cnki.issn.1004-4469.2018.03.011.Ma Y, Deng GD, Ma J, et al. Preliminary investigation of retinal white changes in infants' ocular screenings[J]. Ophthalmol CHN, 2018, 27(3): 211-214. DOI: 10.13281/j.cnki.issn.1004-4469.2018.03.011.
27.	尹虹, 黎晓新, 赵明威, 等. 早产儿视网膜病变激光治疗的疗效分析[J]. 眼科研究, 2007, 25(3): 208-210. DOI: 10.3760/cma.j.issn.2095-0160.2007.03.014.Yin H, Li XX, Zhao MW, et al. Treatment outcome of retinopathy of premeturity by laser photocoagulation[J]. Chin Ophthal Res, 2007, 25(3): 208-210. DOI: 10.3760/cma.j.issn.2095-0160.2007.03.014.
28.	尹虹, 黎晓新, 梁建宏, 等. 影响1区早产儿视网膜病变激光治疗结果的因素分析[J]. 中华眼底病杂志, 2010, 26(1): 58-60. DOI: 10.3760/cma.j.issn.1005-1015.2010.01.15.Yin H, Li XX, Liang JH, et al. Analysis on factors influencing for results of laser treatment of zone one retinopathy of premature[J]. Chin J Ocul Fundus Dis, 2010, 26(1): 58-60. DOI: 10.3760/cma.j.issn.1005-1015.2010.01.15.
29.	VanderVeen DK, Melia M, Yang MB, et al. Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the American Academy of Ophthalmology[J]. Ophthalmology, 2017, 124(5): 619-633. DOI: 10.1016/j.ophtha.2016.12.025.
30.	Çömez A, Karaküçük Y, Özmen MC, et al. The results of intravitreal bevacizumab monotherapy for treating aggressive posterior retinopathy of prematurity and type 1 retinopathy of prematurity[J]. Eye (Lond), 2021, 35(12): 3302-3310. DOI: 10.1038/s41433-021-01413-4.
31.	Honda S, Hirabayashi H, Tsukahara Y, et al. Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity[J]. Graefe's Arch Clin Exp Ophthalmol, 2008, 246(7): 1061-1063. DOI: 10.1007/s00417-008-0786-7.
32.	Huang Q, Zhang Q, Xu Y, et al. Asymmetric outcomes of type 1 retinopathy of prematurity after bilateral intravitreal ranibizumab treatment[J/OL]. J Ophthalmol, 2017, 2017: 1741386[2017-05-22]. https://pubmed.ncbi.nlm.nih.gov/28341474/. DOI: 10.1155/2017/1741386.
33.	Van Geest RJ, Lesnik-Oberstein SY, Tan HS, et al. A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy[J]. Br J Ophthalmol, 2012, 96(4): 587-590. DOI: 10.1136/bjophthalmol-2011-301005.
34.	王雨生. 我国早产儿视网膜病变三级防治网建设的设想与实践[J]. 中华眼底病杂志, 2014, 30(1): 6-8. DOI: 10.3760/cma.j.issn.1005-1015.2014.01.002.Wang YS. Ideas and practices of construction of tertiary prevention network of retinopathy of prematurity in China[J]. Chin J Ocul Fundus Dis, 2014, 30(1): 6-8. DOI: 10.3760/cma.j.issn.1005-1015.2014.01.002.
35.	Mukherjee AN, Watts P, Al-Madfai H, et al. Impact of retinopathy of prematurity screening examination on cardiorespiratory indices: a comparison of indirect ophthalmoscopy and retcam imaging[J]. Ophthalmology, 2006, 113(9): 1547-1552. DOI: 10.1016/j.ophtha.2006.03.056.
36.	Chiang MF, Wang L, Busuioc M, et al. Telemedical retinopathy of prematurity diagnosis: accuracy, reliability, and image quality[J]. Arch Ophthalmol, 2007, 125(11): 1531-1538. DOI: 10.1001/archopht.125.11.1531.
37.	Roth DB, Morales D, Feuer WJ, et al. Screening for retinopathy of prematurity employing the retcam 120: sensitivity and specificity[J]. Arch Ophthalmol, 2001, 119(2): 268-272.

1. 中华医学会眼科学分会眼底病学组. 中国早产儿视网膜病变筛查指南(2014年)[J]. 中华眼科杂志, 2014, 50(12): 933-935. DOI: 10.3760/cma.j.issn.0412-4081.2014.12.017.Fundus Disease Group of Ophthalmology Branch of Chinese Medical Association. Guidelines for Retinopathy of Prematurity Screening in China (2014)[J]. Chin J Ophthalmol, 2014, 50(12): 933-935. DOI: 10.3760/cma.j.issn.0412-4081.2014.12.017.
2. Hellström A, Smith LE, Dammann O. Retinopathy of prematurity[J]. Lancet, 2013, 382(9902): 1445-1457. DOI: 10.1016/S0140-6736(13)60178-6.
3. 王雨生, 张自峰, 李曼红, 等. 西安地区早产儿视网膜病变筛查的初步结果[J]. 中华眼科杂志, 2010, 46(2): 119-124. DOI: 10.3760/cma.j.issn.0412-4081.2010.02.006.Wang YS, Zhang ZF, Li HM, et al. Preliminary results of screening of retinopathy of prematurity in Xi'an[J]. Chin J Ophthalmol, 2010, 46(2): 119-124. DOI: 10.3760/cma.j.issn.0412-4081.2010.02.006.
4. 张国明, 曾键, 黄丽娜, 等. 深圳早产儿视网膜病变筛查结果分析[J]. 中华眼底病杂志, 2008, 24(1): 38-40.Zhang GM, Zeng J, Huang LN, et al. Screening results of retinopathy of prematurity in preterm infants in 3 hospitals in Shenzhen[J]. Chin J Ocul Fundus Dis, 2008, 24(1): 38-40.
5. 苏钰, 陈长征, 李璐, 等. 湖北地区早产儿视网膜病变筛查结果及相关因素分析[J]. 中华眼底病杂志, 2012, 28(1): 53-56. DOI: 10.3760/cma.j.issn.1005-1015.2012.01.014.Su Y, Cheng CZ, Li L, et al. Screening and risk factors analysis of retinopathy of prematurity in Hubei[J]. Chin J Ocul Fundus Dis, 2012, 28(1): 53-56. DOI: 10.3760/cma.j.issn.1005-1015.2012.01.014.
6. 赵家良. “视觉2020”行动与我国防盲治盲工作[J]. 中华眼科杂志, 2002, 38(10): 577-579. DOI: 10.3760/j:issn:0412-4081.2002.10.001.Zhao JL. "Vision 2020" and prevention of blindness in China[J]. Chin J Ophthalmol, 2002, 38(10): 577-579. DOI: 10.3760/j:issn:0412-4081.2002.10.001.
7. 玛依努尔·于苏甫, 王宁利. “视觉2020”: 中国防盲治盲与眼健康工作进展[J]. 中华医学杂志, 2020, 100(48): 3831-3834. DOI: 10.3760/cma.j.cn112137-20200825-02468.Mayinuer YSF, Wang NL. "Vision 2020": the progress of blindness prevention and eye health in China[J]. Natl Med J China, 2020, 100(48): 3831-3834. DOI: 10.3760/cma.j.cn112137-20200825-02468.
8. 黎晓新. 重视早产儿视网膜病变的防治[J]. 中华眼科杂志, 2005, 41(4): 289-291. DOI: 10.3760/j:issn:0412-4081.2005.04.001.Li XX. Emphasizing the prevention and treatment for retinopathy of prematurity[J]. Chin J Ophthalmol, 2005, 41(4): 289-291. DOI: 10.3760/j:issn:0412-4081.2005.04.001.
9. 赵培泉, 张琦, 许宇. 提高小儿视网膜疾病的认知水平, 推动我国小儿视网膜疾病研究的深入开展[J]. 中华眼底病杂志, 2014, 30(1): 1-5. DOI: 10.3760/cma.j.issn.1005-1015.2014.01.001.Zhao PQ, Zhang Q, Xu Y. The diagnosis and treatment of pediatric retinal disease[J]. Chin J Ocul Fundus Dis, 2014, 30(1): 1-5. DOI: 10.3760/cma.j.issn.1005-1015.2014.01.001.
10. 王雨生, 李蓉. 重视我国早产儿视网膜病变的防治工作[J]. 中华眼科杂志, 2011, 47(6): 483-486. DOI: 10.3760/cma.j.issn.0412-4081.2011.06.002.Wang YS, Li R. Pay attention to the prevention and treatment of retinopathy of prematurity in China[J]. Chin J Ophthalmol, 2011, 47(6): 483-486. DOI: 10.3760/cma.j.issn.0412-4081.2011.06.002.
11. 陆方. 开展小儿视网膜疾病影像检查, 提高小儿视网膜疾病诊断治疗水平[J]. 中华眼底病杂志, 2014, 30(1): 9-11. DOI: 10.3760/cma.j.issn.1005-1015.2014.01.003.Lu F. Imaging technology and the diagnosis and treatment of pediatric retinal disease[J]. Chin J Ocul Fundus Dis, 2014, 30(1): 9-11. DOI: 10.3760/cma.j.issn.1005-1015.2014.01.003.
12. 儿童眼及视力保健技术规范[J]. 中华眼科杂志, 2013, 49(7): 651-652. DOI: 10.3760/cma.j.issn.0412-4081.2013.07.017.Technical specification for children's eye and vision care[J]. Chin J Ophthalmol, 2013, 49(7): 651-652. DOI: 10.3760/cma.j.issn.0412-4081.2013.07.017.
13. Emerson MV, Pieramici DJ, Stoessel KM, et al. Incidence and rate of disappearance of retinal hemorrhage in newborns[J]. Ophthalmology, 2001, 108(1): 36-39. DOI: 10.1016/s0161-6420(00)00474-7.
14. Callaway NF, Ludwig CA, Blumenkranz MS, et al. Retinal and optic nerve hemorrhages in the newborn infant: one-year results of the newborn eye screen test study[J]. Ophthalmology, 2016, 123(5): 1043-1052. DOI: 10.1016/j.ophtha.2016.01.004.
15. 李丽红, 李娜, 卢军, 等. 昆明市妇幼保健院新生儿眼病筛查4年回顾[J]. 中国妇幼保健杂志, 2015, 30(18): 2686-2690. DOI: 10.7620/zgfybj.j.issn.1001-4411.2015.18.33.Li LH, Li N, Lu J, et al. Review of neonatal eye disease screening in Kunming Maternal and Child Health Hospital in 4 years[J]. Maternal & Child Health Care of China, 2015, 30(18): 2686-2690. DOI: 10.7620/zgfybj.j.issn.1001-4411.2015.18.33.
16. 张建萍, 马金瑜, 韦丽芳, 等. 新生儿眼底出血及其相关影响因素分析[J]. 中华眼底病杂志, 2015, 31(2): 153-156. DOI: 10.3760/cma.j.issn.1005-1015.2015.02.011.Zhang JP, Ma JY, Wei LF, et al. Retinal hemorrhages in newborns and associated factors[J]. Chin J Ocul Fundus Dis, 2015, 31(2): 153-156. DOI: 10.3760/cma.j.issn.1005-1015.2015.02.011.
17. 杜婉丽, 吴彩云, 张瑜, 等. 足月新生儿眼底出血的高危因素分析[J]. 中国斜视与小儿眼科杂志, 2017, 25(2): 6-9. DOI: 10.3969/J.ISSN.1005-328X.2017.02.002.Du WL, Wu CY, Zhang Y, et al. The high-risk factors for newborn fundus hemorrhages[J]. Chinese Journal of Strabismus & Pediatric Ophthalmology, 2017, 25(2): 6-9. DOI: 10.3969/J.ISSN.1005-328X.2017.02.002.
18. 朱文珲, 骆荣江, 刘韶瑞. 高危新生儿眼底出血临床分析[J]. 中华眼底病杂志, 2012, 28(5): 482-484. DOI: 10.3760/cma.j.issn.1005-1015.2012.05.012.Zhu WH, Luo RJ, Liu SR. Clinical analysis of retinal hemorrhages in high-risk infants[J]. Chin J Ocul Fundus Dis, 2012, 28(5): 482-484. DOI: 10.3760/cma.j.issn.1005-1015.2012.05.012.
19. Egge K, Lyng G, Maltau JM. Retinal haemorrhages in the newborn[J]. Acta Ophthalmol (Copenh), 1980, 58(2): 231-236. DOI: 10.1111/j.1755-3768.1980.tb05715.x.
20. Egge K, Lyng G, Maltau JM. Effect of instrumental delivery on the frequency and severity of retinal hemorrhages in the newborn[J]. Acta Obstet Gynecol Scand, 1981, 60(2): 153-155.
21. Watts P, Maguire S, Kwok T, et al. Newborn retinal hemorrhages: a systematic review[J]. J AAPOS, 2013, 17(1): 70-78. DOI: 10.1016/j.jaapos.2012.07.012.
22. Von Barsewisch B. Perinatal retinal haemorrhages: morphology, aetiology, and significance[M]. New York: Springer-Verlag, 1979: 71-118.
23. Berkus MD, Ramamurthy RS, O'Connor PS, et al. Cohort study of silastic obstetric vacuum cup deliveries: Ⅰ. safety of the instrument[J]. Obstet Gynecol, 1985, 66(4): 503-509.
24. 李丽红, 张国明, 李娜, 等. 新生儿视网膜出血分级标准探讨[J]. 中国妇幼保健, 2017, 32(15): 3572-3574. DOI: 10.7620/zgfybj.j.issn.1001-4411.2017.15.60.Li LH, Zhang GM, Li N, et al. Discussion on the grading standard of neonatal retinal hemorrhage[J]. Maternal & Child Health Care of China, 2017, 32(15): 3572-3574. DOI: 10.7620/zgfybj.j.issn.1001-4411.2017.15.60.
25. Tang H, Li N, Li Z, et al. Collaborating group of neonatal ocular birth defects and genetic diseases in China. Fundus examination of 199 851 newborns by digital imaging in China: a multicentre cross-sectional study[J]. Br J Ophthalmol, 2018, 102(12): 1742-1746. DOI: 10.1136/bjophthalmol-2018-312366.
26. 马燕, 邓光达, 麻婧, 等. 婴幼儿眼病筛查中视网膜白色病灶的病因初探[J]. 眼科, 2018, 27(3): 211-214. DOI: 10.13281/j.cnki.issn.1004-4469.2018.03.011.Ma Y, Deng GD, Ma J, et al. Preliminary investigation of retinal white changes in infants' ocular screenings[J]. Ophthalmol CHN, 2018, 27(3): 211-214. DOI: 10.13281/j.cnki.issn.1004-4469.2018.03.011.
27. 尹虹, 黎晓新, 赵明威, 等. 早产儿视网膜病变激光治疗的疗效分析[J]. 眼科研究, 2007, 25(3): 208-210. DOI: 10.3760/cma.j.issn.2095-0160.2007.03.014.Yin H, Li XX, Zhao MW, et al. Treatment outcome of retinopathy of premeturity by laser photocoagulation[J]. Chin Ophthal Res, 2007, 25(3): 208-210. DOI: 10.3760/cma.j.issn.2095-0160.2007.03.014.
28. 尹虹, 黎晓新, 梁建宏, 等. 影响1区早产儿视网膜病变激光治疗结果的因素分析[J]. 中华眼底病杂志, 2010, 26(1): 58-60. DOI: 10.3760/cma.j.issn.1005-1015.2010.01.15.Yin H, Li XX, Liang JH, et al. Analysis on factors influencing for results of laser treatment of zone one retinopathy of premature[J]. Chin J Ocul Fundus Dis, 2010, 26(1): 58-60. DOI: 10.3760/cma.j.issn.1005-1015.2010.01.15.
29. VanderVeen DK, Melia M, Yang MB, et al. Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the American Academy of Ophthalmology[J]. Ophthalmology, 2017, 124(5): 619-633. DOI: 10.1016/j.ophtha.2016.12.025.
30. Çömez A, Karaküçük Y, Özmen MC, et al. The results of intravitreal bevacizumab monotherapy for treating aggressive posterior retinopathy of prematurity and type 1 retinopathy of prematurity[J]. Eye (Lond), 2021, 35(12): 3302-3310. DOI: 10.1038/s41433-021-01413-4.
31. Honda S, Hirabayashi H, Tsukahara Y, et al. Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity[J]. Graefe's Arch Clin Exp Ophthalmol, 2008, 246(7): 1061-1063. DOI: 10.1007/s00417-008-0786-7.
32. Huang Q, Zhang Q, Xu Y, et al. Asymmetric outcomes of type 1 retinopathy of prematurity after bilateral intravitreal ranibizumab treatment[J/OL]. J Ophthalmol, 2017, 2017: 1741386[2017-05-22]. https://pubmed.ncbi.nlm.nih.gov/28341474/. DOI: 10.1155/2017/1741386.
33. Van Geest RJ, Lesnik-Oberstein SY, Tan HS, et al. A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy[J]. Br J Ophthalmol, 2012, 96(4): 587-590. DOI: 10.1136/bjophthalmol-2011-301005.
34. 王雨生. 我国早产儿视网膜病变三级防治网建设的设想与实践[J]. 中华眼底病杂志, 2014, 30(1): 6-8. DOI: 10.3760/cma.j.issn.1005-1015.2014.01.002.Wang YS. Ideas and practices of construction of tertiary prevention network of retinopathy of prematurity in China[J]. Chin J Ocul Fundus Dis, 2014, 30(1): 6-8. DOI: 10.3760/cma.j.issn.1005-1015.2014.01.002.
35. Mukherjee AN, Watts P, Al-Madfai H, et al. Impact of retinopathy of prematurity screening examination on cardiorespiratory indices: a comparison of indirect ophthalmoscopy and retcam imaging[J]. Ophthalmology, 2006, 113(9): 1547-1552. DOI: 10.1016/j.ophtha.2006.03.056.
36. Chiang MF, Wang L, Busuioc M, et al. Telemedical retinopathy of prematurity diagnosis: accuracy, reliability, and image quality[J]. Arch Ophthalmol, 2007, 125(11): 1531-1538. DOI: 10.1001/archopht.125.11.1531.
37. Roth DB, Morales D, Feuer WJ, et al. Screening for retinopathy of prematurity employing the retcam 120: sensitivity and specificity[J]. Arch Ophthalmol, 2001, 119(2): 268-272.

Previous Article
Prevention and treatment of avoidable blindness in infants and young children
Next Article
Pay attention to the study of spontaneous regression of retinopathy of prematurity

Chinese Journal of Ocular Fundus Diseases

Strengthen the construction of tertiary prevention and treatment network of retinopathy of prematurity in China

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content